SCHEMBL21647726

SCHEMBL21647726

CCOC(=O)CCc1cc(F)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.51
CYP4A11 Q02928 3/20 0.51
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 2/20 0.42
EGFR P00533 1/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
APP P05067 1/20 0.41
CYP4Z1 Q86W10 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29592629 0.84 EGFR (0.56) KDM4EHSD17B10MEN1KMT2AHPGD
SCHEMBL21437996 0.84 EGFR (0.56) KDM4EHSD17B10MEN1KMT2AHPGD
SCHEMBL490901 0.84 EGFR (0.56) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL22566901 0.84 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL2691039 0.84 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1GAAMEN1
SCHEMBL31248058 0.84 CYP4F2 (0.50) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL3906109 0.83 CYP4F2 (0.53) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL21465435 0.82 TSHR (0.49) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL27792899 0.82 CYP4F2 (0.49) CYP4F2CYP4A11ALDH1A1GAAKDM4E
SCHEMBL490899 0.82 CYP4F2 (0.54) CYP4F2CYP4A11ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188023-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2025-06-12 US disclosed
US-12258308-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2025-03-25 US disclosed
CN-112513011-B Benzene derivatives 小野药品工业株式会社 2023-06-16 CN disclosed
US-20220089532-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-24 US disclosed
US-11261154-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-01 US disclosed
US-20210332009-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 US disclosed
EP-3831810-A1 BENZENE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2021-06-09 EP disclosed
CN-112513011-A Benzene derivatives 小野药品工业株式会社 2021-03-16 CN disclosed
WO-2020027150-A1 BENZENE DERIVATIVE 小野薬品工業株式会社 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258308-B2 Benzene derivative PMP22, TMBIM6, MYT1 CYP4F2 2972/4885CYP4A11 2997/4885ALDH1A1 1189/4885
US-11261154-B2 Benzene derivative PMP22, TMBIM6, MYT1 CYP4F2 2972/4885CYP4A11 2997/4885ALDH1A1 1189/4885
US-20250188023-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 CYP4F2 2953/4885CYP4A11 2903/4885ALDH1A1 1203/4885
US-20210332009-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 CYP4F2 2972/4885CYP4A11 2997/4885ALDH1A1 1189/4885
US-20220089532-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 CYP4F2 2972/4885CYP4A11 2997/4885ALDH1A1 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.